HEPATITIS C COMMUNITY
Predictive factors for development of cirrhosis in parenterally acquired chronic ...

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients


Stanislas Pola,  , Hélène Fontainea, Françoise Carnotb, Hervé Zylberberga, Pierre Berthelota, Christian Bréchota, c and Bertrand Nalpasa, c
a Unité d'Hépatologie, Hôpital Laënnec, Paris, France
b INSERM U-370, Hôpital Necker, Paris, France
c Laboratoire d'Anatomo-pathologie, Hôpital Laënnec, Paris, France
Received 18 September 1997;  revised 19 January 1998;  accepted 10 February 1998.  Available online 16 November 2001.
Abstract
Background/Aims: The aim of this study was to evaluate the impact of the host immune status and of virological and environmental parameters on the development of cirrhosis during chronic hepatitis C virus infection.
Methods: Liver histology (cirrhosis or not, Knodell score) was evaluated according to age, sex, route and age of contamination, alcohol consumption and immune status in a large series of 553 HBsAg-negative patients (whose duration of hepatitis C virus infection could be precisely evaluated) divided into three groups: group 1 consisted of 462 immunocompetent subjects (46.1% intravenous drug users, 53.9% transfused), infected for a mean of 12.5±6.7 years, including 16.6% of alcohol abusers (>80 g/day); groups 2a and 2b consisted of 91 immunocompromised patients, 52 human immunodeficiency virus-coinfected patients corresponding to group 2a and 39 kidney recipients undergoing immunosuppressive therapy for group 2b, having been infected by hepatitis C virus for a mean of 12.6±5.3 and 11.5±5.3 years, respectively.
Results: Group 1: cirrhosis was present in 11.0% of group 1 patients and in 23.6% of immunocompetent patients with a duration of hepatitis C virus infection of 20 years or more. Forty-three percent of patients with cirrhosis and with hepatitis C virus infection for more than 20 years were alcohol abusers. The time taken to develop cirrhosis was 14±7 years in patients infected before the age of 40 years as compared to 8±5 years in those infected after 40 years (p<0.001). Groups 2a and 2b: cirrhosis was present in 19.8% of immunocompromised patients, a significantly higher rate than in immunocompetent patients (p<0.01). Alcohol abuse did not increase the risk of cirrhosis in this group. All patients but one were infected by hepatitis C virus before the age of 40 and the calculated time elapsed until the occurrence of cirrhosis was 12.4±5.5 years. In groups 1, 2a and 2b, there was no relation between histological severity, hepatitis C virus genotype and viral load. Four variables were independently associated with the occurrence of cirrhosis in the multivariate analysis: age over 40 at time of contamination (RR=9.3 in age range 40 to 59 and 91.2 in ≥60 years); long duration (≥20 years) of hepatitis C virus infection (RR=15.4); alcohol consumption over 80 g/d (RR=2.9); and human immunodeficiency virus-coinfection (RR=2.6).
Conclusions: Our study on a large series of well-characterized patients provides an accurate evaluation of the risk of cirrhosis in parenterally-contaminated immunocompetent hepatitis C virus-infected patients, with an overall figure of 11%. It also demonstrates the impact of the host immune status on the risk of severe histological lesions during chronic hepatitis C virus infection. It finally establishes the importance of age at the time of viral infection in the occurrence of cirrhosis, as well as the importance of alchol consumption. Thus, at least following parenteral infection, both host-related and environmental cofactors play a major role in the severity of the liver lesions associated with hepatitis C virus infection.


Author Keywords: Cirrhosis; Hepatitis C virus; Immune deficiency

Correspondence: Stanislas Pol, Service d'Hépatologie, Hôpital Necker, 149 Rue de Sèvres, 75747 Paris Cedex 15, France. Tel: (33) (1) 44.49.44.38. Fax: (33) (1) 44.49.44.39.
no issues many of us may be dealing with....as we age.  

Related Discussions
Post a Comment
To
Comment
Post A Comment
Go
Blank
Weight Tracker
Reach your weight goal faster
Start Tracking Now
MedHelp Health Answers
Submit
Top Hepatitis Answerers
Avatar_m_tn
Blank
willbb
Avatar_m_tn
Blank
copyman
Avatar_m_tn
Blank
jmjm530
223152_tn?1321976790
Blank
frijole
Midland, TX
Avatar_m_tn
Blank
mikesimon
179856_tn?1333550962
Blank
nygirl7
Planet Earth, CT
RSS Expert Activity
1741471_tn?1336957856
Blank
LIVE WEBINAR TOMORROW!-SUPER BODY, ... Blank
May 22 by Michael Gonzalez-WallaceBlank
2126606_tn?1335910182
Blank
Fibromyalgia Awareness
May 11 by Clare Waismann Kavin, RASBlank
2126606_tn?1335910182
Blank
Opioid-induced hyperalgesia reduces...
May 03 by Clare Waismann Kavin, RASBlank